In 1980, Ludwig and colleagues described the histologic features of a newly identified chronic liver condition referred to as nonalcoholic steatohepatitis (NASH) and noted that the majority of the ...

Fatty liver disease linked to diabetes and obesity can easily progress to liver cirrhosis, but new research suggests that GLP-1 medicines like Ozempic can help stop that. In a new decades-long study, ...

Shares of Altimmune rose on positive trial results for its treatment for metabolic dysfunction-associated steatohepatitis, or MASH, a liver disease. The stock climbed 7.5% to $5.43 in premarket ...

With the rising epidemic of obesity, metabolic syndrome, and type 2 diabetes mellitus in China, metabolic dysfunction-associated non-alcoholic fatty liver disease has become the most prevalent chronic ...

What Is Metabolic Dysfunction-Associated Steatohepatitis? Metabolic dysfunction-associated steatohepatitis, or MASH, is a form of liver disease. MASH occurs when fat accumulates in liver cells. Plenty ...

The liver, hidden deep in the abdomen, often signals trouble through visible changes on the face, according to three leading ...

The FDA expanded the indication for semaglutide (Wegovy) to treating adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), the agency announced. The glucagon-like peptide-1 ...

Explore the latest findings in liver cirrhosis treatment to reduce liver damage and improve vascular function with new ...

Early treatment and healthy lifestyle changes can help the liver heal and prevent further damage. Complete abstinence from alcohol is crucial in treating alcohol-related liver disease. The life ...

Your face serves as a remarkable window into your overall health, often revealing internal problems long before you experience obvious symptoms. When it comes to fatty liver disease, one of the most ...